a theory about the connection of insulin resistance and inflammation in an evolutionary perspective, emphasizing the role of the TNF system in insulin resistance. They argued for a role of TNF-receptor (TNFR)-2 in these states, observing a strong correlation between plasma soluble TNFR-2 concentrations, body mass index (BMI) and the degree of insulinaemia. They found that TNFR-2 seemed to be independently associated with insulin resistance [2] .
The role of tumour necrosis factor (TNF)-a resistance in obesity and insulin resistance Dear Sir, Fernandez-Real et al. have recently published [1] a theory about the connection of insulin resistance and inflammation in an evolutionary perspective, emphasizing the role of the TNF system in insulin resistance. They argued for a role of TNF-receptor (TNFR)-2 in these states, observing a strong correlation between plasma soluble TNFR-2 concentrations, body mass index (BMI) and the degree of insulinaemia. They found that TNFR-2 seemed to be independently associated with insulin resistance [2] .
In agreement with their findings we have also observed that in patients with gestational diabetes (GDM, n = 30, age: X ± SE, 28.0 ± 0.5 years, BMI 32.5 ± 1.2 kg/m 2 ) the serum TNF-a (6.3 ± 0.15 pg/ml, ELISA, Sigma [St. Louis, Mich., USA], p < 0.01, Mann-Whitney), as well as soluble TNFR-1 (2.9 ± 0.1 ng/ml, non-significant) and TNFR-2 (9.3 ± 1.3 ng/ml, p < 0.05, both ELISA, Bender MedSystem, Vienna, Austria) levels were higher than in healthy pregnant women (n = 30, age: 27.0 ± 0.5 years, BMI: 25.0 ± 0.5 kg/m 2 , serum TNF-a: 4.23 ± 0.07 pg/ml, TNFR-1: 2.4 ± 0.2, TNFR-2: 5.8 ± 0.4 ng/ml) and healthy lean women who were not pregnant and were matched with them (n = 15, age: 28.0 ± 0.2 years, BMI: 23.1 ± 0.9 kg/m 2 , TNF-a: 4.1 ± 0.1 pg/ml, TNFR-1: 2.0 ± 0.1, TNFR-2: 3.3 ± 0.2 ng/ml). In GDM patients; both serum TNFa (Spearman, r s = 0.71) and TNFR-2 (r s = 0.56) were found to be in significant positive linear correlation with fasting C-peptide concentrations (serum C-peptide in GDM patients: 6.01 ± 0.5; in healthy pregnant women: 1.86 ± 0.22; in non-pregnant lean women: 1.40 ± 0.80 ng/ml, RIA, Biodata, Italy). We could also calculate a significant correlation between serum TNF-a and BMI (r s = 0.62). These correlations were not observed either in healthy pregnant women or lean control subjects.
Moreover, the ratio of TNFR-2:TNFR-1 was also significantly higher in patients with GDM (3.2 ± 0.1) compared with normal pregnant women (2.40 ± 0.09, p < 0.02) and lean healthy women (1.6 ± 0.1, p < 0.01) and was found to be in a significant positive linear correlation with the fasting C-peptide concentration (r s = 0.48) and with serum TNF-a concentration (r s = 0.51) in this group. These relations were not observed either in normal pregnant women or in non-pregnant women.
The increased TNF-a levels in insulin-resistant states (e. g. Type II [non-insulin-dependent] diabetes mellitus, GDM and android-type obesity) could represent a TNF-a resistance too. The simultaneous overexpression of TNF-a and its receptors on the neighbouring cells of the fat tissue should result in an apoptosis of the adipocytes, mutually stimulating their programmed cell death through the TNFR-1 death domain-mediated caspase cascade activation [3] . This type of interaction leading to apoptosis obviously is missing in the fat tissue of patients with obesity. Altered apoptotic sensitivity of the normal human preadipocytes (obtained from a visceral and subcutaneous source) to TNF-a has been described previously [4] . Moreover, an overexpression of the anti-apoptotic protein, cIAP2, has also been detected in visceral adipocytes [5] . We suggest that the apoptotic resistance of adipocytes (mainly of those in the visceral fat tissue) to TNF-a contributes to the pathophysiology of obesity and obesity-induced insulin resistance.
The differential expression of the two TNFR-s (R-1 and R-2) ± the former is responsible for signalling of apopotosis, the latter may induce anti-apoptotic mechanisms ± can alter the physiological interplay of the two receptors [4] . The overproduction of the TNFR-2 on the one hand can be a privotal factor for adipocytes to avoid apoptosis and on the other it can also contribute to the insulin resistance of the cells. The principal mechanism of TNF-a resistance in obesity can either come from the increased removal of the transmembranebound forms of the cytokine and its receptors, due to an activation of the recently characterised transmembrane metalloprotease TACE [6] (this possibility accords with the increased soluble TNF-a [7] and TNFR-1 and TNFR-2 level in patients with Type II diabetes, GDM and android-type obesity, respectively) or from an increased expression of anti-apoptotic proteins in adipocytes induced by TNFR-2 or from both of these mechanisms.
The TNF-a resistance of adipocytes in obesity can be a basic difference to clarify the role of the cytokine both in cachexia and in obesity.
Yours sincerely, K. Cseh, G. Winkler, Z. Melczer, E. Baranyi
